Choosing the Right In Vitro Test for Your Monoclonal Genetic Engineering News Consider Rituximab, a mAb approved for the treatment of lymphoma and rheumatoid arthritis. Rituximab works by recognizing a specific protein, CD20, that sits on the surface of B cells. When the mAb targets the protein, it signals the human immune ... |
